Xencor (XNCR) Stock Forecast, Price Target & Predictions
XNCR Stock Forecast
Xencor stock forecast is as follows: an average price target of $42.60 (represents a 76.76% upside from XNCR’s last price of $24.10) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
XNCR Price Target
XNCR Analyst Ratings
Buy
Xencor Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jun 14, 2024 | Etzer Darout | BMO Capital | - | - | 53.15% | 32.78% |
Jun 14, 2024 | Gregory Renza | RBC Capital | - | - | 47.69% | 28.63% |
Apr 16, 2024 | Kaveri Pohlman | BTIG | - | - | 88.96% | 57.68% |
Oct 04, 2021 | Charles Zhu | Guggenheim | - | - | 52.03% | 124.07% |
May 05, 2021 | Dane Leone | Raymond James | - | - | 42.30% | 140.66% |
10
Xencor Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 3 |
Avg Price Target | - | - | $33.67 |
Last Closing Price | $24.10 | $24.10 | $24.10 |
Upside/Downside | -100.00% | -100.00% | 39.71% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 26, 2024 | RBC Capital | Outperform | Outperform | Hold |
Jun 14, 2024 | BMO Capital | Outperform | Outperform | Hold |
Jun 14, 2024 | RBC Capital | Outperform | Outperform | Hold |
May 10, 2024 | Wedbush | Buy | Buy | Hold |
Apr 16, 2024 | Wedbush | Buy | Buy | Hold |
Apr 16, 2024 | BTIG | Buy | Buy | Hold |
Feb 28, 2024 | Wedbush | Buy | Buy | Hold |
Feb 28, 2024 | RBC Capital | Underperform | Underperform | Hold |
Dec 06, 2022 | Cowen & Co. | Outperform | Initialise | |
Oct 13, 2022 | Raymond James | Strong Buy | Upgrade |
10
Xencor Financial Forecast
Xencor Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $44.69M | $59.16M | $45.52M | $18.96M | $21.61M | $27.30M | $30.18M | $85.50M | $154.01M | $19.68M | $67.45M | $33.97M | $41.85M | $35.37M | $13.09M | $32.38M | $3.52M | $21.76M |
Avg Forecast | $20.57M | $20.57M | $20.57M | $20.57M | $21.63M | $15.17M | $16.12M | $14.82M | $17.36M | $14.59M | $20.00M | $23.07M | $77.63M | $30.01M | $26.25M | $28.72M | $20.07M | $21.05M | $34.01M | $26.14M | $76.29M | $20.74M | $18.51M | $16.01M | $30.51M | $36.01M | $11.71M | $14.64M | $14.31M | $6.72M |
High Forecast | $28.72M | $28.72M | $28.72M | $28.72M | $30.19M | $21.17M | $22.50M | $19.69M | $29.60M | $14.76M | $20.56M | $23.07M | $121.33M | $30.01M | $36.65M | $40.10M | $28.02M | $21.05M | $34.01M | $26.14M | $76.29M | $20.74M | $18.51M | $16.01M | $30.51M | $36.01M | $11.71M | $14.64M | $14.31M | $6.72M |
Low Forecast | $12.00M | $12.00M | $12.00M | $12.00M | $12.62M | $8.85M | $9.40M | $11.58M | $1.27M | $14.42M | $19.44M | $23.07M | $11.03M | $30.01M | $15.32M | $16.76M | $11.71M | $21.05M | $34.01M | $26.14M | $76.29M | $20.74M | $18.51M | $16.01M | $30.51M | $36.01M | $11.71M | $14.64M | $14.31M | $6.72M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 7 | 6 | 5 | 5 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.58% | 1.97% | 1.73% | 0.66% | 1.08% | 1.30% | 0.89% | 3.27% | 2.02% | 0.95% | 3.64% | 2.12% | 1.37% | 0.98% | 1.12% | 2.21% | 0.25% | 3.24% |
Forecast
Xencor EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 7 | 6 | 5 | 5 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-33.47M | $-18.27M | $-26.00M | $-59.37M | $-42.59M | $-41.41M | $-19.23M | $32.07M | $75.17M | $-38.20M | $54.00M | $-849.00K | $1.52M | $-11.10M | $-33.58M | $-6.70M | $-25.98M | $-9.50M |
Avg Forecast | $-6.02M | $-6.02M | $-6.02M | $-6.02M | $-6.33M | $-4.44M | $-4.72M | $-4.34M | $-5.08M | $-4.27M | $-5.85M | $-6.75M | $-22.72M | $-8.78M | $-7.68M | $-8.40M | $-5.87M | $-6.88M | $-11.12M | $-8.55M | $-24.95M | $-6.78M | $-6.05M | $-1.48M | $-9.98M | $-11.77M | $-3.83M | $-9.84M | $-4.68M | $-2.20M |
High Forecast | $-3.51M | $-3.51M | $-3.51M | $-3.51M | $-3.69M | $-2.59M | $-2.75M | $-3.39M | $-371.89K | $-4.22M | $-5.69M | $-6.75M | $-3.23M | $-8.78M | $-4.48M | $-4.90M | $-3.43M | $-6.88M | $-11.12M | $-8.55M | $-24.95M | $-6.78M | $-6.05M | $-1.19M | $-9.98M | $-11.77M | $-3.83M | $-7.87M | $-4.68M | $-2.20M |
Low Forecast | $-8.40M | $-8.40M | $-8.40M | $-8.40M | $-8.83M | $-6.19M | $-6.58M | $-5.76M | $-8.66M | $-4.32M | $-6.02M | $-6.75M | $-35.50M | $-8.78M | $-10.72M | $-11.73M | $-8.20M | $-6.88M | $-11.12M | $-8.55M | $-24.95M | $-6.78M | $-6.05M | $-1.78M | $-9.98M | $-11.77M | $-3.83M | $-11.81M | $-4.68M | $-2.20M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.47% | 2.08% | 3.38% | 7.06% | 7.25% | 6.02% | 1.73% | -3.75% | -3.01% | 5.63% | -8.92% | 0.57% | -0.15% | 0.94% | 8.77% | 0.68% | 5.55% | 4.32% |
Forecast
Xencor Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 7 | 6 | 5 | 5 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-19.10M | $-24.27M | $-21.95M | $-59.92M | $-12.04M | $-32.76M | $-39.95M | $23.59M | $73.06M | $-40.19M | $52.25M | $-2.49M | $-13.69K | $-12.55M | $-35.02M | $-8.07M | $-26.91M | $-10.22M |
Avg Forecast | $-56.98M | $-56.98M | $-57.62M | $-57.62M | $-57.88M | $-58.00M | $-57.62M | $-56.34M | $-51.79M | $-62.82M | $-53.19M | $90.05M | $-6.79M | $-46.50M | $-51.03M | $71.18M | $866.88M | $-41.70M | $-30.46M | $56.27M | $1.73M | $-38.92M | $-36.19M | $-4.34M | $-23.36M | $-13.79M | $-31.64M | $-11.86M | $-25.35M | $-33.64M |
High Forecast | $-26.12M | $-26.12M | $-26.41M | $-26.41M | $-26.53M | $-26.59M | $-26.41M | $-51.33M | $-43.65M | $-28.80M | $-24.38M | $108.06M | $25.46M | $-21.31M | $-23.39M | $85.42M | $1.04B | $-41.70M | $-30.46M | $67.53M | $1.73M | $-38.92M | $-36.19M | $-3.47M | $-23.36M | $-13.79M | $-31.64M | $-9.48M | $-25.35M | $-33.64M |
Low Forecast | $-86.32M | $-86.32M | $-87.29M | $-87.29M | $-87.68M | $-87.87M | $-87.29M | $-68.23M | $-62.27M | $-95.18M | $-80.59M | $72.04M | $-35.64M | $-70.45M | $-77.32M | $56.95M | $693.50M | $-41.70M | $-30.46M | $45.02M | $1.73M | $-38.92M | $-36.19M | $-5.21M | $-23.36M | $-13.79M | $-31.64M | $-14.23M | $-25.35M | $-33.64M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.81% | 0.52% | 0.43% | -0.84% | -0.01% | 0.79% | 1.31% | 0.42% | 42.29% | 1.03% | -1.44% | 0.57% | 0.00% | 0.91% | 1.11% | 0.68% | 1.06% | 0.30% |
Forecast
Xencor SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 7 | 6 | 5 | 5 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $15.27M | $12.49M | $11.46M | $13.95M | $12.75M | $12.37M | $11.09M | $11.27M | $11.38M | $10.37M | $8.86M | $8.23M | $7.60M | $7.64M | $7.23M | $7.22M | $6.75M | $6.27M |
Avg Forecast | $4.71M | $4.71M | $4.71M | $4.71M | $4.95M | $3.47M | $3.69M | $3.39M | $3.97M | $3.34M | $4.57M | $5.28M | $17.76M | $6.86M | $6.01M | $6.57M | $4.59M | $4.53M | $7.32M | $5.62M | $16.41M | $4.46M | $3.98M | $14.36M | $6.56M | $7.74M | $2.52M | $10.60M | $3.08M | $1.45M |
High Forecast | $6.57M | $6.57M | $6.57M | $6.57M | $6.91M | $4.84M | $5.15M | $4.51M | $6.77M | $3.38M | $4.70M | $5.28M | $27.75M | $6.86M | $8.38M | $9.17M | $6.41M | $4.53M | $7.32M | $5.62M | $16.41M | $4.46M | $3.98M | $17.24M | $6.56M | $7.74M | $2.52M | $12.72M | $3.08M | $1.45M |
Low Forecast | $2.74M | $2.74M | $2.74M | $2.74M | $2.89M | $2.02M | $2.15M | $2.65M | $290.75K | $3.30M | $4.45M | $5.28M | $2.52M | $6.86M | $3.50M | $3.83M | $2.68M | $4.53M | $7.32M | $5.62M | $16.41M | $4.46M | $3.98M | $11.49M | $6.56M | $7.74M | $2.52M | $8.48M | $3.08M | $1.45M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.86% | 1.82% | 1.91% | 2.12% | 2.78% | 2.73% | 1.52% | 2.00% | 0.69% | 2.33% | 2.23% | 0.57% | 1.16% | 0.99% | 2.87% | 0.68% | 2.19% | 4.33% |
Forecast
Xencor EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 7 | 6 | 5 | 5 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.31 | $-0.40 | $-0.37 | $-1.00 | $-0.20 | $-0.55 | $-0.67 | $0.40 | $1.25 | $-0.69 | $0.90 | $-0.04 | $-0.00 | $-0.22 | $-0.61 | $-0.14 | $-0.47 | $-0.18 |
Avg Forecast | $-0.89 | $-0.89 | $-0.90 | $-0.90 | $-0.90 | $-0.91 | $-0.90 | $-0.88 | $-0.81 | $-0.98 | $-0.83 | $-0.83 | $-0.11 | $-0.73 | $-0.80 | $-0.66 | $-0.79 | $-0.68 | $-0.49 | $-0.55 | $0.03 | $-0.63 | $-0.59 | $-0.67 | $-0.38 | $-0.22 | $-0.51 | $-0.38 | $-0.41 | $-0.55 |
High Forecast | $-0.41 | $-0.41 | $-0.41 | $-0.41 | $-0.41 | $-0.42 | $-0.41 | $-0.80 | $-0.68 | $-0.45 | $-0.38 | $-0.38 | $0.40 | $-0.33 | $-0.37 | $-0.30 | $-0.36 | $-0.68 | $-0.49 | $-0.55 | $0.03 | $-0.63 | $-0.59 | $-0.67 | $-0.38 | $-0.22 | $-0.51 | $-0.38 | $-0.41 | $-0.55 |
Low Forecast | $-1.35 | $-1.35 | $-1.36 | $-1.36 | $-1.37 | $-1.37 | $-1.36 | $-1.07 | $-0.97 | $-1.49 | $-1.26 | $-1.26 | $-0.56 | $-1.10 | $-1.21 | $-1.00 | $-1.19 | $-0.68 | $-0.49 | $-0.55 | $0.03 | $-0.63 | $-0.59 | $-0.67 | $-0.38 | $-0.22 | $-0.51 | $-0.38 | $-0.41 | $-0.55 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.92% | 0.55% | 0.46% | 1.51% | 0.25% | 0.81% | 1.36% | -0.73% | 44.63% | 1.09% | -1.53% | 0.06% | 0.00% | 0.98% | 1.19% | 0.37% | 1.14% | 0.33% |
Forecast
Xencor Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
STRO | Sutro Biopharma | - | - | 340.32% | Buy |
LRMR | Larimar Therapeutics | - | - | 231.65% | Buy |
FIXX | Q32 Bio | - | - | 190.32% | Buy |
KURA | Kura Oncology | - | - | 158.45% | Buy |
MLYS | Mineralys Therapeutics | - | - | 152.74% | Buy |
ERAS | Erasca | - | - | 150.00% | Buy |
ANAB | AnaptysBio | - | - | 145.63% | Buy |
SNDX | Syndax Pharmaceuticals | - | - | 119.87% | Buy |
REPL | Replimune Group | - | - | 119.00% | Buy |
VRDN | Viridian Therapeutics | - | - | 93.27% | Buy |
KROS | Keros Therapeutics | - | - | 90.56% | Buy |
XNCR | Xencor | - | - | 76.76% | Buy |
IDYA | IDEAYA Biosciences | - | - | 75.11% | Buy |
MRUS | Merus | - | - | 72.84% | Buy |
MGTX | MeiraGTx | - | - | 52.03% | Buy |
EWTX | Edgewise Therapeutics | - | - | 40.71% | Buy |
PCVX | Vaxcyte | - | - | 40.29% | Buy |
DICE | DICE Therapeutics | - | - | 26.18% | Buy |
NUVL | Nuvalent | - | - | 20.32% | Buy |
PTGX | Protagonist Therapeutics | - | - | 20.05% | Buy |
ACLX | Arcellx | - | - | -4.84% | Buy |
CERE | Cerevel Therapeutics | - | - | -25.49% | Buy |